Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level

Multiple sclerosis (MS) is a disabling inflammatory demyelinating disease of the central nervous system, considered to result from self-reactivity to myelin antigens. Tumor necrosis factor (TNF) and the p55 TNF receptor (TNFR) have been strongly implicated in MS pathogenesis. We reveal in this study a dual role for TNF in experimental autoimmune encephalomyelitis (EAE), a mouse model for MS. In addition to its well-established proinflammatory effects, TNF exhibits potent immunosuppressive properties, providing one possible explanation for the immune and disease activating effect of anti-TNF treatment of MS. We show that in TNF-deficient mice, myelin-specific T cell reactivity fails to regress and expansion of activated/memory T cells is abnormally prolonged, leading to exacerbated EAE. Strikingly, immnosuppression by TNF and protection against EAE does not require the p55 TNFR, whereas the same receptor is necessary for the detrimental effects of TNF during the acute phase of the disease. Thus, blocking the function of the p55 TNFR in autoimmune demyelination may inhibit the noxious proinflammatory activities of TNF without compromising its immunosuppressive properties.

[1]  T. Mak,et al.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.

[2]  G. Kollias,et al.  Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor , 2000, European journal of immunology.

[3]  L. Steinman,et al.  Assessment of Animal Models for MS and Demyelinating Disease in the Design of Rational Therapy , 1999, Neuron.

[4]  E. Sercarz,et al.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.

[5]  S. Hanauer,et al.  Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. , 1999, Inflammatory bowel diseases.

[6]  H. Mcdevitt,et al.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. , 1988, Nature.

[7]  R. Locksley,et al.  Immunological tolerance to a pancreatic antigen as a result of local expression of TNFalpha by islet beta cells. , 1997, Immunity.

[8]  G. Kollias,et al.  A tumor necrosis factor‐induced model of human primary demyelinating diseases develops in immunodeficient mice , 1999, European journal of immunology.

[9]  M. Feldmann,et al.  Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. , 1999, Journal of immunology.

[10]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[11]  C. Jacob,et al.  Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis , 1988, Nature.

[12]  M. Pasparakis,et al.  TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein‐induced experimental autoimmune encephalomyelitis , 1999, European journal of immunology.

[13]  G. Wong,et al.  TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination , 1998, Nature Medicine.

[14]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[15]  K. Frei,et al.  Severity of symptoms and demyelination in MOG‐induced EAE depends on TNFR1 , 1999, European journal of immunology.

[16]  V. Tuohy,et al.  Spontaneous Regression of Primary Autoreactivity during Chronic Progression of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis , 1999, The Journal of experimental medicine.

[17]  S. Wittmer,et al.  Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.

[18]  P. Henkart,et al.  Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. , 1995, Journal of immunology.

[19]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[20]  F. Barkhof,et al.  Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 , 1996, Neurology.

[21]  D. Paty,et al.  TNF neutralization in MS , 1999, Neurology.

[22]  H. Weiner,et al.  MS: a CNS and systemic autoimmune disease. , 1989, Immunology today.

[23]  J. Pollard,et al.  Critical Points of Tumor Necrosis Factor Action in Central Nervous System Autoimmune Inflammation Defined by Gene Targeting , 1997, The Journal of experimental medicine.

[24]  D. Goeddel,et al.  Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice , 1994, Nature.

[25]  M. Sharief,et al.  Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .

[26]  G. Kelsoe,et al.  Alternative pathways for the selection of antigen-specific peripheral T cells , 1996, Nature.

[27]  T. Mak,et al.  Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo , 1996, European journal of immunology.

[28]  David D. Chaplin,et al.  Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.

[29]  A. Cope.  Regulation of autoimmunity by proinflammatory cytokines. , 1998, Current opinion in immunology.

[30]  R. Locksley,et al.  Immunological Tolerance to a Pancreatic Antigen as a Result of Local Expression of TNFα by Islet β Cells , 1997 .

[31]  M. Odeh,et al.  Role of cytokines in rheumatoid arthritis. , 1998, Drug news & perspectives.

[32]  G. Kollias,et al.  Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. , 1998, The American journal of pathology.